This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 10939779

PUBLISHED SUBJECT

2024000171 - MEDICAMENTOS GRUPO 4 - SANGUE

Parties involved

Place of performance
Portugal
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Bidder
LABORATÓRIOS ATRAL, S.A. · Tax ID 500162085
Bidder
Overpharma, Lda · Tax ID 505792362
Bidder
SANDOZ FARMACÊUTICA, LDA. · Tax ID 506985261
Bidder
Amgen Biofarmacêutica, Lda · Tax ID 502942959
Bidder
ACCORD HEALTHCARE , UNIPESSOAL LDA · Tax ID 508622263
Bidder
VIFOR PHARMA PORTUGAL, SA · Tax ID 516677586
Bidder
GENERIS – FARMACEUTICA, S.A. · Tax ID 508107997
Bidder
LEO FARMACÊUTICOS, LIMITADA · Tax ID 503932680
Bidder
B BRAUN MEDICAL, LDA. · Tax ID 501506543

Values and timeline

Contract price
€161.10
Procedure base price
€38,564.82
Total effective price
Not reported on Portal BASE
Publication date
27 September 2024
Award date
19 June 2024
Signing date
19 June 2024
Performance period
91 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Award criterion
Multifator
CPV code
33652000-5 - Antineoplásicos e imunomoduladores
Legal basis
Artigo 20.º, n.º 1, alínea b) do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement
Not stated
Centralised procedure
No
Environmental criterion
No
Notice
9952/2024
Procedure identifier
7076509

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts